Hematologist and oncologist Sarah Holstein, MD, PhD, is leading a nationwide study to test the effectiveness of a new placentaderived natural killer (NK) cell therapy.
Mike Hadfield recently completed the first marathon of his life. And it happened while he was recovering from cancer in the halls of the Fred & Pamela Buffett Cancer Center.
In June of 2017, when the Fred & Pamela Buffett Cancer Center first opened for patient care on the Nebraska Medical Center campus, lead donor Pamela Buffett could not have predicted she would be sitting in one of its rooms just over three years later, comforting her newfound friend – a friend who was preparing to die from a devastating disease that has ripped far too many people from the arms of their loved ones.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?